Caszyme was featured in Biocompare’s article “CRISPR Editing in Stem Cells”!
Our Senior Scientist, Tomas Urbaitis, and CEO, Monika Paule, discuss the challenges of stem cell editing and CRISPR’s potential in personalized therapies.
Read more about it here: https://www.biocompare.com/Editorial-Articles/614748-CRISPR-Editing-in-Stem-Cells/?arev=true?utm_source=linkedin&utm_medium=social